VIP and HIV-1 infection: Because activation of the receptors VPAC1 and VPAC2 has previously resulted in opposite effects during HIV-1 infection [27], [28], we initially investigated whether the neuropeptides VIP and PACAP, the natural ligands of those receptors, would also affect HIV-1 replication.